nodes	percent_of_prediction	percent_of_DWPC	metapath
Aztreonam—Mouth ulceration—Sorafenib—liver cancer	0.0197	0.0197	CcSEcCtD
Aztreonam—Dermatitis exfoliative—Sorafenib—liver cancer	0.0168	0.0168	CcSEcCtD
Aztreonam—Vaginal moniliasis—Epirubicin—liver cancer	0.016	0.016	CcSEcCtD
Aztreonam—Vulvovaginal candidiasis—Epirubicin—liver cancer	0.0153	0.0153	CcSEcCtD
Aztreonam—Vaginal moniliasis—Doxorubicin—liver cancer	0.0148	0.0148	CcSEcCtD
Aztreonam—Vulvovaginal mycotic infection—Epirubicin—liver cancer	0.0148	0.0148	CcSEcCtD
Aztreonam—Local reaction—Epirubicin—liver cancer	0.0146	0.0146	CcSEcCtD
Aztreonam—Aspartate aminotransferase increased—Sorafenib—liver cancer	0.0143	0.0143	CcSEcCtD
Aztreonam—Toxic epidermal necrolysis—Sorafenib—liver cancer	0.0143	0.0143	CcSEcCtD
Aztreonam—Vulvovaginal candidiasis—Doxorubicin—liver cancer	0.0142	0.0142	CcSEcCtD
Aztreonam—Alanine aminotransferase increased—Sorafenib—liver cancer	0.014	0.014	CcSEcCtD
Aztreonam—Vulvovaginal mycotic infection—Doxorubicin—liver cancer	0.0137	0.0137	CcSEcCtD
Aztreonam—Local reaction—Doxorubicin—liver cancer	0.0135	0.0135	CcSEcCtD
Aztreonam—Serum creatinine increased—Epirubicin—liver cancer	0.0131	0.0131	CcSEcCtD
Aztreonam—Thrombocytosis—Epirubicin—liver cancer	0.013	0.013	CcSEcCtD
Aztreonam—Neutropenia—Sorafenib—liver cancer	0.0128	0.0128	CcSEcCtD
Aztreonam—Serum creatinine increased—Doxorubicin—liver cancer	0.0121	0.0121	CcSEcCtD
Aztreonam—Thrombocytosis—Doxorubicin—liver cancer	0.012	0.012	CcSEcCtD
Aztreonam—Stomatitis—Sorafenib—liver cancer	0.0119	0.0119	CcSEcCtD
Aztreonam—Jaundice—Sorafenib—liver cancer	0.0119	0.0119	CcSEcCtD
Aztreonam—Haemoglobin—Sorafenib—liver cancer	0.011	0.011	CcSEcCtD
Aztreonam—Haemorrhage—Sorafenib—liver cancer	0.011	0.011	CcSEcCtD
Aztreonam—Erythema multiforme—Sorafenib—liver cancer	0.0104	0.0104	CcSEcCtD
Aztreonam—Tinnitus—Sorafenib—liver cancer	0.0102	0.0102	CcSEcCtD
Aztreonam—Flushing—Sorafenib—liver cancer	0.0102	0.0102	CcSEcCtD
Aztreonam—Petechiae—Epirubicin—liver cancer	0.00981	0.00981	CcSEcCtD
Aztreonam—Erythema—Sorafenib—liver cancer	0.00954	0.00954	CcSEcCtD
Aztreonam—Dysgeusia—Sorafenib—liver cancer	0.00935	0.00935	CcSEcCtD
Aztreonam—Petechiae—Doxorubicin—liver cancer	0.00907	0.00907	CcSEcCtD
Aztreonam—Ventricular extrasystoles—Epirubicin—liver cancer	0.00893	0.00893	CcSEcCtD
Aztreonam—Anaemia—Sorafenib—liver cancer	0.00882	0.00882	CcSEcCtD
Aztreonam—Angioedema—Sorafenib—liver cancer	0.00872	0.00872	CcSEcCtD
Aztreonam—Cough—Sorafenib—liver cancer	0.00833	0.00833	CcSEcCtD
Aztreonam—Ventricular extrasystoles—Doxorubicin—liver cancer	0.00827	0.00827	CcSEcCtD
Aztreonam—Myalgia—Sorafenib—liver cancer	0.00813	0.00813	CcSEcCtD
Aztreonam—Vaginal inflammation—Epirubicin—liver cancer	0.00807	0.00807	CcSEcCtD
Aztreonam—Anaphylactic shock—Sorafenib—liver cancer	0.00779	0.00779	CcSEcCtD
Aztreonam—Candida infection—Epirubicin—liver cancer	0.0077	0.0077	CcSEcCtD
Aztreonam—Thrombocytopenia—Sorafenib—liver cancer	0.00763	0.00763	CcSEcCtD
Aztreonam—Vaginal infection—Epirubicin—liver cancer	0.00762	0.00762	CcSEcCtD
Aztreonam—Vaginal inflammation—Doxorubicin—liver cancer	0.00747	0.00747	CcSEcCtD
Aztreonam—Mouth ulceration—Epirubicin—liver cancer	0.00729	0.00729	CcSEcCtD
Aztreonam—Candida infection—Doxorubicin—liver cancer	0.00713	0.00713	CcSEcCtD
Aztreonam—Musculoskeletal discomfort—Sorafenib—liver cancer	0.0071	0.0071	CcSEcCtD
Aztreonam—Vaginal infection—Doxorubicin—liver cancer	0.00705	0.00705	CcSEcCtD
Aztreonam—Dyspnoea—Sorafenib—liver cancer	0.00694	0.00694	CcSEcCtD
Aztreonam—Phlebitis—Epirubicin—liver cancer	0.0068	0.0068	CcSEcCtD
Aztreonam—Thrombophlebitis—Epirubicin—liver cancer	0.00677	0.00677	CcSEcCtD
Aztreonam—Mouth ulceration—Doxorubicin—liver cancer	0.00675	0.00675	CcSEcCtD
Aztreonam—Pain—Sorafenib—liver cancer	0.00666	0.00666	CcSEcCtD
Aztreonam—Vascular purpura—Epirubicin—liver cancer	0.00655	0.00655	CcSEcCtD
Aztreonam—Gastrointestinal pain—Sorafenib—liver cancer	0.00637	0.00637	CcSEcCtD
Aztreonam—Phlebitis—Doxorubicin—liver cancer	0.00629	0.00629	CcSEcCtD
Aztreonam—Thrombophlebitis—Doxorubicin—liver cancer	0.00626	0.00626	CcSEcCtD
Aztreonam—Dermatitis exfoliative—Epirubicin—liver cancer	0.00621	0.00621	CcSEcCtD
Aztreonam—Urticaria—Sorafenib—liver cancer	0.00619	0.00619	CcSEcCtD
Aztreonam—Body temperature increased—Sorafenib—liver cancer	0.00616	0.00616	CcSEcCtD
Aztreonam—Abdominal pain—Sorafenib—liver cancer	0.00616	0.00616	CcSEcCtD
Aztreonam—Purpura—Epirubicin—liver cancer	0.00608	0.00608	CcSEcCtD
Aztreonam—Vascular purpura—Doxorubicin—liver cancer	0.00606	0.00606	CcSEcCtD
Aztreonam—Gastrointestinal haemorrhage—Epirubicin—liver cancer	0.00586	0.00586	CcSEcCtD
Aztreonam—Diplopia—Epirubicin—liver cancer	0.00586	0.00586	CcSEcCtD
Aztreonam—Dermatitis exfoliative—Doxorubicin—liver cancer	0.00574	0.00574	CcSEcCtD
Aztreonam—Hypersensitivity—Sorafenib—liver cancer	0.00574	0.00574	CcSEcCtD
Aztreonam—Purpura—Doxorubicin—liver cancer	0.00562	0.00562	CcSEcCtD
Aztreonam—Asthenia—Sorafenib—liver cancer	0.00559	0.00559	CcSEcCtD
Aztreonam—Pruritus—Sorafenib—liver cancer	0.00551	0.00551	CcSEcCtD
Aztreonam—Blood creatinine increased—Epirubicin—liver cancer	0.00549	0.00549	CcSEcCtD
Aztreonam—Diplopia—Doxorubicin—liver cancer	0.00542	0.00542	CcSEcCtD
Aztreonam—Gastrointestinal haemorrhage—Doxorubicin—liver cancer	0.00542	0.00542	CcSEcCtD
Aztreonam—Diarrhoea—Sorafenib—liver cancer	0.00533	0.00533	CcSEcCtD
Aztreonam—Toxic epidermal necrolysis—Epirubicin—liver cancer	0.00527	0.00527	CcSEcCtD
Aztreonam—Aspartate aminotransferase increased—Epirubicin—liver cancer	0.00527	0.00527	CcSEcCtD
Aztreonam—Alanine aminotransferase increased—Epirubicin—liver cancer	0.00517	0.00517	CcSEcCtD
Aztreonam—Dizziness—Sorafenib—liver cancer	0.00515	0.00515	CcSEcCtD
Aztreonam—Abdominal distension—Epirubicin—liver cancer	0.0051	0.0051	CcSEcCtD
Aztreonam—Blood creatinine increased—Doxorubicin—liver cancer	0.00508	0.00508	CcSEcCtD
Aztreonam—Eosinophilia—Epirubicin—liver cancer	0.00501	0.00501	CcSEcCtD
Aztreonam—Vomiting—Sorafenib—liver cancer	0.00495	0.00495	CcSEcCtD
Aztreonam—Rash—Sorafenib—liver cancer	0.00491	0.00491	CcSEcCtD
Aztreonam—Dermatitis—Sorafenib—liver cancer	0.00491	0.00491	CcSEcCtD
Aztreonam—Toxic epidermal necrolysis—Doxorubicin—liver cancer	0.00488	0.00488	CcSEcCtD
Aztreonam—Aspartate aminotransferase increased—Doxorubicin—liver cancer	0.00488	0.00488	CcSEcCtD
Aztreonam—Headache—Sorafenib—liver cancer	0.00488	0.00488	CcSEcCtD
Aztreonam—Pancytopenia—Epirubicin—liver cancer	0.00481	0.00481	CcSEcCtD
Aztreonam—Alanine aminotransferase increased—Doxorubicin—liver cancer	0.00478	0.00478	CcSEcCtD
Aztreonam—Neutropenia—Epirubicin—liver cancer	0.00473	0.00473	CcSEcCtD
Aztreonam—Abdominal distension—Doxorubicin—liver cancer	0.00472	0.00472	CcSEcCtD
Aztreonam—Eosinophilia—Doxorubicin—liver cancer	0.00464	0.00464	CcSEcCtD
Aztreonam—Nausea—Sorafenib—liver cancer	0.00463	0.00463	CcSEcCtD
Aztreonam—Pancytopenia—Doxorubicin—liver cancer	0.00445	0.00445	CcSEcCtD
Aztreonam—Stomatitis—Epirubicin—liver cancer	0.0044	0.0044	CcSEcCtD
Aztreonam—Jaundice—Epirubicin—liver cancer	0.0044	0.0044	CcSEcCtD
Aztreonam—Neutropenia—Doxorubicin—liver cancer	0.00438	0.00438	CcSEcCtD
Aztreonam—Haemoglobin—Epirubicin—liver cancer	0.00407	0.00407	CcSEcCtD
Aztreonam—Stomatitis—Doxorubicin—liver cancer	0.00407	0.00407	CcSEcCtD
Aztreonam—Jaundice—Doxorubicin—liver cancer	0.00407	0.00407	CcSEcCtD
Aztreonam—Hepatitis—Epirubicin—liver cancer	0.00405	0.00405	CcSEcCtD
Aztreonam—Haemorrhage—Epirubicin—liver cancer	0.00405	0.00405	CcSEcCtD
Aztreonam—Erythema multiforme—Epirubicin—liver cancer	0.00383	0.00383	CcSEcCtD
Aztreonam—Tinnitus—Epirubicin—liver cancer	0.00378	0.00378	CcSEcCtD
Aztreonam—Haemoglobin—Doxorubicin—liver cancer	0.00377	0.00377	CcSEcCtD
Aztreonam—Flushing—Epirubicin—liver cancer	0.00376	0.00376	CcSEcCtD
Aztreonam—Haemorrhage—Doxorubicin—liver cancer	0.00375	0.00375	CcSEcCtD
Aztreonam—Hepatitis—Doxorubicin—liver cancer	0.00375	0.00375	CcSEcCtD
Aztreonam—Erythema multiforme—Doxorubicin—liver cancer	0.00354	0.00354	CcSEcCtD
Aztreonam—Erythema—Epirubicin—liver cancer	0.00353	0.00353	CcSEcCtD
Aztreonam—Tinnitus—Doxorubicin—liver cancer	0.0035	0.0035	CcSEcCtD
Aztreonam—Flushing—Doxorubicin—liver cancer	0.00348	0.00348	CcSEcCtD
Aztreonam—Dysgeusia—Epirubicin—liver cancer	0.00345	0.00345	CcSEcCtD
Aztreonam—Ill-defined disorder—Epirubicin—liver cancer	0.00327	0.00327	CcSEcCtD
Aztreonam—Erythema—Doxorubicin—liver cancer	0.00326	0.00326	CcSEcCtD
Aztreonam—Anaemia—Epirubicin—liver cancer	0.00326	0.00326	CcSEcCtD
Aztreonam—Dysgeusia—Doxorubicin—liver cancer	0.0032	0.0032	CcSEcCtD
Aztreonam—Malaise—Epirubicin—liver cancer	0.00318	0.00318	CcSEcCtD
Aztreonam—Vertigo—Epirubicin—liver cancer	0.00317	0.00317	CcSEcCtD
Aztreonam—Cough—Epirubicin—liver cancer	0.00308	0.00308	CcSEcCtD
Aztreonam—Convulsion—Epirubicin—liver cancer	0.00306	0.00306	CcSEcCtD
Aztreonam—Ill-defined disorder—Doxorubicin—liver cancer	0.00303	0.00303	CcSEcCtD
Aztreonam—Anaemia—Doxorubicin—liver cancer	0.00302	0.00302	CcSEcCtD
Aztreonam—Myalgia—Epirubicin—liver cancer	0.003	0.003	CcSEcCtD
Aztreonam—Chest pain—Epirubicin—liver cancer	0.003	0.003	CcSEcCtD
Aztreonam—Discomfort—Epirubicin—liver cancer	0.00297	0.00297	CcSEcCtD
Aztreonam—Malaise—Doxorubicin—liver cancer	0.00294	0.00294	CcSEcCtD
Aztreonam—Vertigo—Doxorubicin—liver cancer	0.00293	0.00293	CcSEcCtD
Aztreonam—Confusional state—Epirubicin—liver cancer	0.0029	0.0029	CcSEcCtD
Aztreonam—Anaphylactic shock—Epirubicin—liver cancer	0.00288	0.00288	CcSEcCtD
Aztreonam—Cough—Doxorubicin—liver cancer	0.00285	0.00285	CcSEcCtD
Aztreonam—Convulsion—Doxorubicin—liver cancer	0.00283	0.00283	CcSEcCtD
Aztreonam—Thrombocytopenia—Epirubicin—liver cancer	0.00282	0.00282	CcSEcCtD
Aztreonam—Hyperhidrosis—Epirubicin—liver cancer	0.00278	0.00278	CcSEcCtD
Aztreonam—Chest pain—Doxorubicin—liver cancer	0.00278	0.00278	CcSEcCtD
Aztreonam—Myalgia—Doxorubicin—liver cancer	0.00278	0.00278	CcSEcCtD
Aztreonam—Discomfort—Doxorubicin—liver cancer	0.00275	0.00275	CcSEcCtD
Aztreonam—Hypotension—Epirubicin—liver cancer	0.00269	0.00269	CcSEcCtD
Aztreonam—Confusional state—Doxorubicin—liver cancer	0.00269	0.00269	CcSEcCtD
Aztreonam—Anaphylactic shock—Doxorubicin—liver cancer	0.00266	0.00266	CcSEcCtD
Aztreonam—Musculoskeletal discomfort—Epirubicin—liver cancer	0.00262	0.00262	CcSEcCtD
Aztreonam—Thrombocytopenia—Doxorubicin—liver cancer	0.00261	0.00261	CcSEcCtD
Aztreonam—Insomnia—Epirubicin—liver cancer	0.0026	0.0026	CcSEcCtD
Aztreonam—Paraesthesia—Epirubicin—liver cancer	0.00258	0.00258	CcSEcCtD
Aztreonam—Hyperhidrosis—Doxorubicin—liver cancer	0.00257	0.00257	CcSEcCtD
Aztreonam—Dyspnoea—Epirubicin—liver cancer	0.00257	0.00257	CcSEcCtD
Aztreonam—Hypotension—Doxorubicin—liver cancer	0.00249	0.00249	CcSEcCtD
Aztreonam—Pain—Epirubicin—liver cancer	0.00246	0.00246	CcSEcCtD
Aztreonam—Musculoskeletal discomfort—Doxorubicin—liver cancer	0.00243	0.00243	CcSEcCtD
Aztreonam—Insomnia—Doxorubicin—liver cancer	0.00241	0.00241	CcSEcCtD
Aztreonam—Paraesthesia—Doxorubicin—liver cancer	0.00239	0.00239	CcSEcCtD
Aztreonam—Dyspnoea—Doxorubicin—liver cancer	0.00237	0.00237	CcSEcCtD
Aztreonam—Feeling abnormal—Epirubicin—liver cancer	0.00237	0.00237	CcSEcCtD
Aztreonam—Gastrointestinal pain—Epirubicin—liver cancer	0.00235	0.00235	CcSEcCtD
Aztreonam—Urticaria—Epirubicin—liver cancer	0.00229	0.00229	CcSEcCtD
Aztreonam—Pain—Doxorubicin—liver cancer	0.00228	0.00228	CcSEcCtD
Aztreonam—Body temperature increased—Epirubicin—liver cancer	0.00228	0.00228	CcSEcCtD
Aztreonam—Abdominal pain—Epirubicin—liver cancer	0.00228	0.00228	CcSEcCtD
Aztreonam—Feeling abnormal—Doxorubicin—liver cancer	0.00219	0.00219	CcSEcCtD
Aztreonam—Gastrointestinal pain—Doxorubicin—liver cancer	0.00218	0.00218	CcSEcCtD
Aztreonam—Hypersensitivity—Epirubicin—liver cancer	0.00212	0.00212	CcSEcCtD
Aztreonam—Urticaria—Doxorubicin—liver cancer	0.00212	0.00212	CcSEcCtD
Aztreonam—Abdominal pain—Doxorubicin—liver cancer	0.00211	0.00211	CcSEcCtD
Aztreonam—Body temperature increased—Doxorubicin—liver cancer	0.00211	0.00211	CcSEcCtD
Aztreonam—Asthenia—Epirubicin—liver cancer	0.00207	0.00207	CcSEcCtD
Aztreonam—Pruritus—Epirubicin—liver cancer	0.00204	0.00204	CcSEcCtD
Aztreonam—Diarrhoea—Epirubicin—liver cancer	0.00197	0.00197	CcSEcCtD
Aztreonam—Hypersensitivity—Doxorubicin—liver cancer	0.00196	0.00196	CcSEcCtD
Aztreonam—Asthenia—Doxorubicin—liver cancer	0.00191	0.00191	CcSEcCtD
Aztreonam—Dizziness—Epirubicin—liver cancer	0.0019	0.0019	CcSEcCtD
Aztreonam—Pruritus—Doxorubicin—liver cancer	0.00188	0.00188	CcSEcCtD
Aztreonam—Vomiting—Epirubicin—liver cancer	0.00183	0.00183	CcSEcCtD
Aztreonam—Diarrhoea—Doxorubicin—liver cancer	0.00182	0.00182	CcSEcCtD
Aztreonam—Rash—Epirubicin—liver cancer	0.00182	0.00182	CcSEcCtD
Aztreonam—Dermatitis—Epirubicin—liver cancer	0.00181	0.00181	CcSEcCtD
Aztreonam—Headache—Epirubicin—liver cancer	0.0018	0.0018	CcSEcCtD
Aztreonam—Dizziness—Doxorubicin—liver cancer	0.00176	0.00176	CcSEcCtD
Aztreonam—Nausea—Epirubicin—liver cancer	0.00171	0.00171	CcSEcCtD
Aztreonam—Vomiting—Doxorubicin—liver cancer	0.00169	0.00169	CcSEcCtD
Aztreonam—Rash—Doxorubicin—liver cancer	0.00168	0.00168	CcSEcCtD
Aztreonam—Dermatitis—Doxorubicin—liver cancer	0.00168	0.00168	CcSEcCtD
Aztreonam—Headache—Doxorubicin—liver cancer	0.00167	0.00167	CcSEcCtD
Aztreonam—Nausea—Doxorubicin—liver cancer	0.00158	0.00158	CcSEcCtD
